Back to Search Start Over

[Methylene blue therapy for vasoplegia after cardiac surgery].

Authors :
Skuza K
Chmielniak S
Dziuk W
Kucewicz E
Pawlak S
Knapik P
Source :
Anestezjologia intensywna terapia [Anestezjol Intens Ter] 2009 Jul-Sep; Vol. 41 (3), pp. 159-62.
Publication Year :
2009

Abstract

Background: Systemic inflammatory response syndrome (SIRS) may be associated with critically decreased vascular resistance (vasoplegia syndrome) and become resistant to noradrenaline. Such a condition may be successfully treated with intravenous methylene blue.<br />Case Report: A 73-year-old patient with acute myocardial infarction and cardiogenic shock was admitted to our centre after failed percutaneous coronary interventions to the left anterior descending coronary artery and underwent emergency coronary revascularisation. After surgery, his ejection fraction was 25%. X-ray revealed pulmonary oedema. The patient became severely hypotensive with marked vasoplegia and metabolic acidosis, despite incremental doses of adrenaline and noradrenaline. 2 mg kg(-1) of methylene blue was administered, which quickly stabilized the patient's general condition.<br />Conclusion: Methylene blue applied to vasoplegic patients can effectively increase systemic vascular resistance and restore satisfactory organ perfusion.

Details

Language :
Polish
ISSN :
0209-1712
Volume :
41
Issue :
3
Database :
MEDLINE
Journal :
Anestezjologia intensywna terapia
Publication Type :
Academic Journal
Accession number :
19999604